R. Hindley

Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.

J. Holder, J. Clapham, H. Chapman, 1998, The Journal of pharmacology and experimental therapeutics.

[[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.

Stephen A. Smith, M. Cawthorne, S. Smith, 1994, Journal of medicinal chemistry.

The synthesis of BRL 49653 : a novel and potent antihyperglycaemic agent

David Haigh, Stephen A. Smith, M. Cawthorne, 1994 .

Non-thiazolidinedione antihyperglycaemic agents. Part 4: Synthesis of (±)-, (R)-(+)- and (S)-(−)-enantiomers of 2-oxy-3-arylpropanoic acids

H. Birrell, H. Rami, D. Haigh, 1999 .

Xenobiotic cholesteryl ester formation.

R. Fears, P. Walker, R. M. Hindley, 1982, Xenobiotica; the fate of foreign compounds in biological systems.

The participation of ethyl 4-benzyloxybenzoate (BRL 10894) and other aryl-substituted acids in glycerolipid metabolism.

R. Fears, R. M. Hindley, B. Morgan, 1978, Journal of lipid research.

Non thiazolidinedione antihyperglycaemic agents. 1: α-Heteroatom substituted β-phenylpropanoic acids

David Haigh, Stephen A. Smith, M. Cawthorne, 1996 .